Journal of the Japan Diabetes Society
Online ISSN : 1881-588X
Print ISSN : 0021-437X
ISSN-L : 0021-437X
Search
Advanced search
OR
Browse
Search
Volume 58, Issue 3
Displaying 1-8 of 8 articles from this issue
Show all abstracts
    • |<
    • <
    • 1
    • >
    • >|
Original Articles
Diagnosis, Treatment
Psychology, Behaviour Science
  • Creation of an Exercise Self-efficacy Scale for Diabetes Self-care
    Mayumi Otsuji, Nobuyuki Koriyama, Mayumi Kinowaki, Ayako Akao, Yoko Sa ...
    2015 Volume 58 Issue 3 Pages 174-182
    Published: March 30, 2015
    Released on J-STAGE: April 06, 2015
    DOIhttps://doi.org/10.11213/tonyobyo.58.174
    JOURNAL FREE ACCESS
    Show abstractHide abstract
    Assessing the patients' self-efficacy level and developing approaches for improving this parameter is useful. We herein developed a scale for exercise therapy (Exercise Self-Efficacy Scale for Diabetes Self-care; ESESD). The results of an analysis of the ESESD administered in 283 diabetes patients receiving outpatient care at our center showed a Cronbach's α coefficient of 0.93 and a mean score of 32.6±0.44 points. Therefore, the elderly patients tended to have higher levels of self-efficacy. In addition, significant negative correlations were observed for BMI (p=0.0010) and HbA1c (p=0.0270), while a significant positive correlation was noted for SESD (Self-Efficacy Scale for Diabetes self-care) (p=0.0005). These findings indicate that the ESESD may become an important source of information for assessing the exercise self-efficacy levels in diabetes patients or from the perspective of team investigating intervention methods, thus providing guidance for recuperation with a focus on the individual.
    View full abstract
    Download PDF (593K)
  • Self-perception of Glycemic Control in Type-2 Diabetes Patients during and After Cancer Treatment
    Naoko Higo, Terumi Kaneko, Machiko Hasegawa, Sachiko Mitsuki, Hiroya I ...
    2015 Volume 58 Issue 3 Pages 183-191
    Published: March 30, 2015
    Released on J-STAGE: April 06, 2015
    DOIhttps://doi.org/10.11213/tonyobyo.58.183
    JOURNAL FREE ACCESS
    Show abstractHide abstract
    We assessed self-perception of glycemic control in type-2 diabetes patients during and after cancer treatment. A questionnaire survey was performed in 34 type-2 diabetes patients with cancer in their 50's and 60's and 34 type-2 diabetes patients without cancer in their 50's and 60's as the control group. The survey was conducted using a Self-Efficacy Scale for dietary control in diabetes patients, the Locus of Control Scale, and our original questionnaire. The main results of the survey were as follows: 1. There were no significant differences in self-efficacy of dietary management; 2. There were no significant differences in the locus of control; 3. The responses to "Do you wish to concentrate on treatment for both cancer and diabetes?" were biased towards the positives of "strongly agree" and "somewhat agree," whereas self-efficacy was significantly greater in the "strongly agree" group than in the "somewhat agree" group (p=0.0055). These findings suggest that type-2 diabetes patients with cancer exhibit the same level of self-efficacy and locus of control as patients without cancer and have a positive attitude toward treatment for both cancer and diabetes.
    View full abstract
    Download PDF (1297K)
Health Service, Medical Economics
  • Clinical Background Factors of Patients with Advanced Diabetic Retinopathy at the First Presentation
    Rieko Gemma, Kiyoko Kitahara, Eriko Kono, Masaki Imoto, Akira Ikeya, H ...
    2015 Volume 58 Issue 3 Pages 192-197
    Published: March 30, 2015
    Released on J-STAGE: April 06, 2015
    DOIhttps://doi.org/10.11213/tonyobyo.58.192
    JOURNAL FREE ACCESS
    Show abstractHide abstract
    In order to prevent the progression of diabetic complications, the clinical background characteristics of patients with advanced diabetic retinopathy are typically evaluated at the first presentation. Among all patients who visited our department for the first time between April 2008 and March 2012, 107 individuals with diabetes (73 men, 34 women) had pre-proliferative and proliferative diabetic retinopathy, of whom 65 had untreated diabetes (22 received left diabetic care, 20 experienced interrupted treatment and 23 had no prior diagnosis). The average age of the patients who received interrupted treatment was younger. There were more men among the subjects who discontinued care or experienced interrupted care, whereas there were more women among the non-diagnosed cases. Advanced chronic kidney disease (CKD) was noted in 67.1 % and 44.1 % of men and women, respectively. In order to further prevent the progression of diabetic complications, physicians must make efforts to efficiently increase the rate of health checkups based on age, gender and life stage.
    View full abstract
    Download PDF (324K)
Case Reports
  • A Case of Autoimmune Type 1 Diabetes Mellitus Complicated by Myasthenia Gravis and Graves' Disease
    Shoko Nakajima, Masaaki Matsunaga, Miyuki Shibata, Noriko Kusada, Kota ...
    2015 Volume 58 Issue 3 Pages 198-204
    Published: March 30, 2015
    Released on J-STAGE: April 06, 2015
    DOIhttps://doi.org/10.11213/tonyobyo.58.198
    JOURNAL FREE ACCESS
    Show abstractHide abstract
    A 35-year-old woman with type 1 diabetes was admitted to our hospital after reporting general fatigue, palpitations and diplopia in February 20xy. At 15 years of age, she was started on treatment with insulin therapy for type 1 diabetes. Five years later, she received a diagnosis of myasthenia gravis (MG). On admission, a blood test showed apparent Graves' disease, and the patient's glycemic control was poor. Therefore, we began treatment with an insulin pump in addition to thymectomy for MG followed by the administration of tacrolimus and prednisolone as immunosuppressive therapy. Thereafter, tight glycemic control was maintained with adjustments to the basal injection rate. The patient was therefore given a diagnosis of type 3 polyglandular autoimmune syndrome complicated by type 1 diabetes mellitus, MG and Graves' disease in which the difficult to control diabetes was successfully managed with an insulin pump.
    View full abstract
    Download PDF (738K)
  • A Case of Fulminant Type 1 Diabetes Mellitus with Plural Islet-related Autoantibodies
    Mitsue Miyahara, Chihiro Nagano, Shuhei Nakanishi, Yoshinari Furukawa, ...
    2015 Volume 58 Issue 3 Pages 205-211
    Published: March 30, 2015
    Released on J-STAGE: April 06, 2015
    DOIhttps://doi.org/10.11213/tonyobyo.58.205
    JOURNAL FREE ACCESS
    Show abstractHide abstract
    Type 1 diabetes is divided into two categories, autoimmune and idiopathic. Fulminant type 1 diabetes (FT1DM) is a subtype of the idiopathic type, in which islet-related autoantibodies are negative. A 61-year-old woman was admitted to our hospital with the abrupt onset of diabetic ketoacidosis. The plasma fasting glucose level was 30.8 mmol/l, the HbA1c level was 8.5 % (two days earlier: 7.4 %), the plasma C-peptide level was 0.13 ng/ml and the urine C-peptide level was<3.4 μg/day. According to the diagnostic criteria for FT1DM, including the rapid onset of hyperglycemia, ketoacidosis and decreasing insulin secretion, the patient was diagnosed with FT1DM. In this case, the titers of glutamic acid dehydrogenase (GAD) antibodies, insulinoma-associated antigen-2 (IA-2) antibodies, islet cell antibodies (ICA) and insulin autoantibodies (IAA) were all positive, suggesting that islet-associated autoimmunity may be involved in the development of FT1DM, although only a few cases of classical acute-onset type 1 diabetes have been reported to show FT1DM-like onset.
    View full abstract
    Download PDF (441K)
Proceeding of the Local Societies
    • |<
    • <
    • 1
    • >
    • >|
feedback
 Top